Literature DB >> 10376975

Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.

X Wang1, G P Doherty, M K Leith, T J Curphey, A Begleiter.   

Abstract

DT-diaphorase is a two-electron reducing enzyme that activates the bioreductive anti-tumour agent, mitomycin C (MMC). Cell lines having elevated levels of DT-diaphorase are generally more sensitive to MMC. We have shown that DT-diaphorase can be induced in human tumour cells by a number of compounds, including 1,2-dithiole-3-thione. In this study, we investigated whether induction of DT-diaphorase could enhance the cytotoxic activity of MMC in six human tumour cell lines representing four tumour types. DT-diaphorase was induced by many dietary inducers, including propyl gallate, dimethyl maleate, dimethyl fumarate and sulforaphane. The cytotoxicity of MMC was significantly increased in four tumour lines with the increase ranging from 1.4- to threefold. In contrast, MMC activity was not increased in SK-MEL-28 human melanoma cells and AGS human gastric cancer cells, cell lines that have high base levels of DT-diaphorase activity. Toxicity to normal human marrow cells was increased by 50% when MMC was combined with 1,2-dithiole-3-thione, but this increase was small in comparison with the threefold increase in cytotoxicity to tumour cells. This study demonstrates that induction of DT-diaphorase can increase the cytotoxic activity of MMC in human tumour cell lines, and suggests that it may be possible to use non-toxic inducers of DT-diaphorase to enhance the efficacy of bioreductive anti-tumour agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376975      PMCID: PMC2362377          DOI: 10.1038/sj.bjc.6690489

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  56 in total

1.  Purification and properties of NADPH-cytochrome P-450 reductase.

Authors:  H W Strobel; J D Dignam
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

2.  Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.

Authors:  R S Marshall; A M Rauth
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

3.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Combination therapy with nucleoside analogs and alkylating agents.

Authors:  J B Johnston; L Verburg; T Shore; M Williams; L G Israels; A Begleiter
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

5.  Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.

Authors:  C A Pritsos; A C Sartorelli
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

6.  Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA.

Authors:  M Tomasz; R Lipman; D Chowdary; J Pawlak; G L Verdine; K Nakanishi
Journal:  Science       Date:  1987-03-06       Impact factor: 47.728

7.  Reductive activation of mitomycin C by NADH:cytochrome b5 reductase.

Authors:  W F Hodnick; A C Sartorelli
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

8.  Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.

Authors:  Y Zhang; T W Kensler; C G Cho; G H Posner; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones.

Authors:  P A Egner; T W Kensler; T Prestera; P Talalay; A H Libby; H H Joyner; T J Curphey
Journal:  Carcinogenesis       Date:  1994-02       Impact factor: 4.944

Review 10.  DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

Authors:  D Ross; D Siegel; H Beall; A S Prakash; R T Mulcahy; N W Gibson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

View more
  9 in total

Review 1.  Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.

Authors:  Phillip D Bass; Daniel A Gubler; Ted C Judd; Robert M Williams
Journal:  Chem Rev       Date:  2013-05-08       Impact factor: 60.622

2.  Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells.

Authors:  Robert D Bongard; Gary S Krenz; Adam J Gastonguay; Carol L Williams; Brian J Lindemer; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2011-01-14       Impact factor: 7.376

3.  NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.

Authors:  Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

4.  Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent.

Authors:  Xiang Yu; Melanie M Erzinger; Kathryn E Pietsch; Frances N Cervoni-Curet; John Whang; John Niederhuber; Shana J Sturla
Journal:  J Pharmacol Exp Ther       Date:  2012-08-15       Impact factor: 4.030

5.  NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.

Authors:  Georg T Wondrak
Journal:  Free Radic Biol Med       Date:  2007-04-10       Impact factor: 7.376

Review 6.  NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.

Authors:  David Siegel; Chao Yan; David Ross
Journal:  Biochem Pharmacol       Date:  2011-12-24       Impact factor: 6.100

7.  Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.

Authors:  Bingrui Li; Guangsheng Pei; Jun Yao; Qingqing Ding; Peilin Jia; Zhongming Zhao
Journal:  Oncogene       Date:  2021-06-17       Impact factor: 9.867

8.  Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo.

Authors:  A Begleiter; M K Leith; J A Thliveris; T Digby
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

9.  Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A.

Authors:  Melanie M Erzinger; Cédric Bovet; Katrin M Hecht; Sabine Senger; Pascale Winiker; Nadine Sobotzki; Simona Cristea; Niko Beerenwinkel; Jerry W Shay; Giancarlo Marra; Bernd Wollscheid; Shana J Sturla
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.